Raloxifene hydrochloride
| Raloxifene hydrochloride | |
|---|---|
| Term | Raloxifene hydrochloride |
| Short definition | raloxifene hydrochloride - (pronounced) (ra-LOK-sih-feen HY-droh-KLOR-ide) drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of developing this disease or who have osteoporosis, and to prevent and treat osteoporosis in postmenopausal women. Raloxifene hydrochloride is also being studied to treat other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
raloxifene hydrochloride - (pronounced) (ra-LOK-sih-feen HY-droh-KLOR-ide) drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of developing this disease or who have osteoporosis, and to prevent and treat osteoporosis in postmenopausal women. Raloxifene hydrochloride is also being studied to treat other types of cancer. It blocks the effects of the hormone estrogen in breast tissue, which can help prevent breast cancer cells from growing. Raloxifene hydrochloride may also help prevent bone loss. It is a type of Selective Estrogen Receptor Modulator (SERM). Raloxifene is the active ingredient in raloxifene hydrochloride. Also called Evista
External links
- Medical encyclopedia article on Raloxifene hydrochloride
- Wikipedia's article - Raloxifene hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski